Abbonarsi

Seven-point checklist for dermatoscopy: Performance during 10 years of prospective surveillance of patients at increased melanoma risk - 24/04/13

Doi : 10.1016/j.jaad.2009.08.049 
Holger A. Haenssle, MD a, , Bianca Korpas a, Christian Hansen-Hagge a, Timo Buhl, MD a, Kjell M. Kaune, MD a, Albert Rosenberger, MD b, Ullrich Krueger, MD a, Michael P. Schön, MD a, Steffen Emmert, MD a
a Department of Dermatology, Georg August University Göttingen, Göttingen, Germany 
b Department of Genetic Epidemiology, Georg August University Göttingen, Göttingen, Germany 

Reprint requests: Holger A. Haenssle, Department of Dermatology, Georg August University Göttingen, Von Siebold Strasse 3, D 37075 Göttingen, Germany.

Abstract

Background

The retrospectively developed 7-point checklist is one of the most applicable dermatoscopic algorithms for clinical use. However, until today no prospective data on the diagnostic performance of this algorithm were reported.

Objective

Our aim was to assess the sensitivity, specificity, and diagnostic accuracy of the 7-point checklist in the setting of a prospective long-term study.

Methods

Patients at increased melanoma risk (n = 688) were screened at regular intervals by naked-eye examination, the dermatoscopic 7-point checklist, and digital dermatoscopy follow-up (10-year study interval).

Results

We detected 127 melanomas including 50 melanomas in situ. The mean Breslow thickness of invasive melanomas was 0.57 mm. A total of 79 melanomas displayed the 7-point checklist melanoma threshold of 3 or more points (62% sensitivity, compared with 78%-95% in retrospective settings). In all, 48 melanomas scored fewer than 3 points and were excised because of complementary information (eg, lesional history, dynamic changes detected by digital dermatoscopy). The specificity of the 7-point checklist was 97% (compared with 65%-87% in retrospective settings). Regression patterns, atypical vascular patterns, and radial streaming were associated with the highest relative risk for melanoma (odds ratio 3.26, 95% confidence interval 2.05-5.16; odds ratio 3.04, 95% confidence interval 1.70-5.46; odds ratio 2.91, 95% confidence interval 1.64-5.15; P < .0003, respectively). Melanomas thicker than 0.5 mm exhibited significantly more regression patterns and atypical vascular patterns (P < .02). The malignant versus benign ratio for all excised lesions was 1:8.6 (127 melanomas, 1092 nonmelanomas).

Limitations

Calculation of the specificity was a limitation. True negative lesions were defined by a score less than 3 points and either the histopathological diagnosis of nonmelanoma or the absence of dynamic changes during digital dermatoscopy follow-up (nonexcised, nonsuspicious, no change).

Conclusions

The 7-point checklist for dermatoscopy was less sensitive but highly specific in this prospective clinical setting. Complementary information clearly increased the sensitivity. Regression patterns or radial streaming in nevi of patients at high risk should raise a higher melanoma suspicion than might be concluded from retrospective studies.

Il testo completo di questo articolo è disponibile in PDF.

Key words : atypical mole syndrome, atypical mole and multiple melanoma syndrome, dermatoscopy, melanoma, 7-point checklist


Mappa


 Supported in part by the Cancer Society of Lower Saxony (Niedersächsische Krebsgesellschaft e.V., Hannover, Germany). The FotoFinder dermatoscope used in this study is a donation of Teachscreen Software GmbH (Bad Birnbach, Germany) to the University Hospital Göttingen.
 Conflicts of interest: None declared.


© 2010  American Academy of Dermatology, Inc.. Pubblicato da Elsevier Masson SAS. Tutti i diritti riservati.
Aggiungere alla mia biblioteca Togliere dalla mia biblioteca Stampare
Esportazione

    Citazioni Export

  • File

  • Contenuto

Vol 62 - N° 5

P. 785-793 - maggio 2010 Ritorno al numero
Articolo precedente Articolo precedente
  • Change of Address
| Articolo seguente Articolo seguente
  • Use of and beliefs about total body photography and dermatoscopy among US dermatology training programs: An update
  • Vitaly Terushkin, Susan A. Oliveria, Ashfaq A. Marghoob, Allan C. Halpern

Benvenuto su EM|consulte, il riferimento dei professionisti della salute.
L'accesso al testo integrale di questo articolo richiede un abbonamento.

Già abbonato a @@106933@@ rivista ?

@@150455@@ Voir plus

Il mio account


Dichiarazione CNIL

EM-CONSULTE.COM è registrato presso la CNIL, dichiarazione n. 1286925.

Ai sensi della legge n. 78-17 del 6 gennaio 1978 sull'informatica, sui file e sulle libertà, Lei puo' esercitare i diritti di opposizione (art.26 della legge), di accesso (art.34 a 38 Legge), e di rettifica (art.36 della legge) per i dati che La riguardano. Lei puo' cosi chiedere che siano rettificati, compeltati, chiariti, aggiornati o cancellati i suoi dati personali inesati, incompleti, equivoci, obsoleti o la cui raccolta o di uso o di conservazione sono vietati.
Le informazioni relative ai visitatori del nostro sito, compresa la loro identità, sono confidenziali.
Il responsabile del sito si impegna sull'onore a rispettare le condizioni legali di confidenzialità applicabili in Francia e a non divulgare tali informazioni a terzi.


Tutto il contenuto di questo sito: Copyright © 2026 Elsevier, i suoi licenziatari e contributori. Tutti i diritti sono riservati. Inclusi diritti per estrazione di testo e di dati, addestramento dell’intelligenza artificiale, e tecnologie simili. Per tutto il contenuto ‘open access’ sono applicati i termini della licenza Creative Commons.